[
    [
        {
            "time": "",
            "original_text": "国开证券---医药行业点评报告：2月疫苗行业批签发数据点评【行业研究】",
            "features": {
                "keywords": [
                    "国开证券",
                    "医药行业",
                    "疫苗",
                    "批签发数据"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国开证券---医药行业点评报告：2月疫苗行业批签发数据点评【行业研究】",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "名企名品看玉溪|沃森：“我们的梦想在这里实现”",
            "features": {
                "keywords": [
                    "沃森",
                    "梦想",
                    "玉溪"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "名企名品看玉溪|沃森：“我们的梦想在这里实现”",
                "Correlation": 5,
                "Sentiment": 8,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "国盛证券---医药生物行业周报：全民免疫迫在眉睫，新冠疫苗的热点问题怎么看【行业研究】",
            "features": {
                "keywords": [
                    "国盛证券",
                    "医药生物",
                    "新冠疫苗",
                    "全民免疫"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国盛证券---医药生物行业周报：全民免疫迫在眉睫，新冠疫苗的热点问题怎么看【行业研究】",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]